PMID- 18400403 OWN - NLM STAT- MEDLINE DCOM- 20090608 LR - 20131121 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 153 IP - 3 DP - 2008 May 15 TI - Amitriptyline induces nuclear transcription factor-kappaB-dependent glutamate transporter upregulation in chronic morphine-infused rats. PG - 823-31 LID - 10.1016/j.neuroscience.2008.02.055 [doi] AB - We previously showed that intrathecal co-administration of amitriptyline with morphine upregulates the expression of the glial glutamate transporters glutamate-aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1) and restores neuronal glutamate transporter excitatory amino acid carrier 1 (EAAC1) expression in chronically morphine-infused rats. The present study examined the role of nuclear transcription factor-kappaB (NF-kappaB) in the regulation of the expression of GLAST, GLT-1, and EAAC1 following long-term amitriptyline/morphine co-infusion. Male Wistar rats were implanted with two intrathecal catheters with or without a microdialysis probe; one of the catheters was used for continuous infusion of saline (control), morphine (15 microg/h), or morphine plus amitriptyline (both 15 microg/h) for 5 days, while the other was used for a single daily intrathecal injection of the NF-kappaB inhibitor Ro106-9920 (10 microl of 10 microM) for 5 days. We found that amitriptyline co-infusion restored the antinociceptive effect of morphine (4.5-fold right-shift in the morphine dose-response curve compared with a 65-fold right-shift in its absence) and this effect was inhibited by Ro106-9920 administration (48-fold right-shift). Moreover, amitriptyline/morphine co-infusion increased IkappaBalpha phosphorylation and the translocation of NF-kappaB p65 from the cytosol to the nucleus. Daily intrathecal injection of Ro106-9920 prevented the amitriptyline/morphine-induced NF-kappaB p65 translocation and reversed the amitriptyline/morphine-induced GLAST and GLT-1 upregulation and inhibited the restoration of EAAC1 expression. The Ro106-9920 injections abolished the inhibitory effect of amitriptyline on the morphine-evoked release of excitatory amino acids into the spinal cerebrospinal fluid (CSF) dialysates. In conclusion, amitriptyline/morphine co-infusion restores the antinociceptive effect of morphine and upregulates GLAST and GLT-1 expression and restores EAAC1 expression to baseline levels, thus reducing excitatory amino acid levels in the spinal CSF dialysates. The mechanism involves activation of the NF-kappaB pathway, but may also involve other pathways. FAU - Tai, Y-H AU - Tai YH AD - Department of Anesthesiology, Tri-service General Hospital and National Defense Medical Center, Taipei, Taiwan. FAU - Tsai, R-Y AU - Tsai RY FAU - Wang, Y-H AU - Wang YH FAU - Cherng, C-H AU - Cherng CH FAU - Tao, P-L AU - Tao PL FAU - Liu, T-M AU - Liu TM FAU - Wong, C-S AU - Wong CS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080306 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Adrenergic Uptake Inhibitors) RN - 0 (Amino Acid Transport System X-AG) RN - 0 (Excitatory Amino Acids) RN - 0 (NF-kappa B) RN - 0 (Narcotics) RN - 0 (Ro 106-9920) RN - 0 (Sulfoxides) RN - 0 (Tetrazoles) RN - 1806D8D52K (Amitriptyline) RN - 76I7G6D29C (Morphine) SB - IM MH - Adrenergic Uptake Inhibitors/*administration & dosage MH - Amino Acid Transport System X-AG/*drug effects/metabolism MH - Amitriptyline/*administration & dosage MH - Animals MH - Blotting, Western MH - Dose-Response Relationship, Drug MH - Drug Interactions MH - Drug Tolerance/physiology MH - Excitatory Amino Acids/metabolism MH - Fluorescent Antibody Technique MH - Gene Expression Regulation/drug effects MH - Image Processing, Computer-Assisted MH - Injections, Spinal MH - Male MH - Microdialysis MH - Morphine/pharmacology MH - NF-kappa B/*drug effects/metabolism MH - Narcotics/*pharmacology MH - Pain Threshold/drug effects MH - Rats MH - Rats, Wistar MH - Sulfoxides/pharmacology MH - Tetrazoles/pharmacology MH - Up-Regulation EDAT- 2008/04/11 09:00 MHDA- 2009/06/09 09:00 CRDT- 2008/04/11 09:00 PHST- 2007/11/15 00:00 [received] PHST- 2008/02/11 00:00 [revised] PHST- 2008/02/18 00:00 [accepted] PHST- 2008/04/11 09:00 [pubmed] PHST- 2009/06/09 09:00 [medline] PHST- 2008/04/11 09:00 [entrez] AID - S0306-4522(08)00301-1 [pii] AID - 10.1016/j.neuroscience.2008.02.055 [doi] PST - ppublish SO - Neuroscience. 2008 May 15;153(3):823-31. doi: 10.1016/j.neuroscience.2008.02.055. Epub 2008 Mar 6.